Article Details
Retrieved on: 2024-11-11 02:04:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has received approval to market its KRAS G12C inhibitor, Garsora.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here